Costs and cost-effectiveness of the Kerala Pilot Screening Programme for Diabetic Retinopathy in the public health system

Author:

Wittenberg Raphael1,Anderson Robert,Redding StuartORCID,Gopal Bipin,Sadanandan Rajeev,Sahasranamam Vasudeva,George Simon,Premnazir Lakshmi,Netuveli Gopalakrishnan,Srin Jyotsna,Conroy Dolores,Sivaprasad Sobha2ORCID

Affiliation:

1. University of Oxford

2. Moorfields Eye Hospital

Abstract

Abstract Background/Objectives The Government of Kerala initiated a pilot screening programme for diabetic retinopathy in 16 Family Health Centres in Thiruvananthapuram district in 2019 in collaboration with the ORNATE India project. The evaluation of this pilot included a study of its costs and cost-effectiveness to inform decisions about extending the programme throughout Kerala. Subjects/Methods The participants comprise all 5,307 people who were screened for diabetic retinopathy under the pilot programme for whom data could be collected. Results The costs of the pilot programme are estimated at INR 11.3 million ((including INR 1.9 million costs to individuals) and the benefits at 514 QALYs, slightly over one QALY per person treated. The cost per QALY was INR22,000, which is well below India’s Gross National Income per person. Conclusions Kerala’s 2019 pilot screening programme for diabetic retinopathy was highly cost-effective.

Publisher

Research Square Platform LLC

Reference21 articles.

1. Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence;Wong TY;Ophthalmologica,2020

2. Federation I. IDF Diabetes Atlas, 9th edn. 2019.

3. Diabetic retinopathy: An epidemic at home and around the world;Raman R;Indian journal of ophthalmology,2016

4. Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India;Redding S;BMJ Open,2023

5. Perception of care and barriers to treatment in individuals with diabetic retinopathy in India: 11-city 9-state study;Shukla R;Indian journal of endocrinology and metabolism,2016

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3